Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prebiotics × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Anus Neoplasms 1

Interventions

Oxaliplatin 1173 Fluorouracil 1096 Capecitabine 896 Gemcitabine 868 Leucovorin 777 Irinotecan 681 Bevacizumab 654 Cisplatin 556 Radiotherapy 463 Cetuximab 390 pembrolizumab 359 Paclitaxel 330 Nivolumab 271 Drug Therapy 265 130-nm albumin-bound paclitaxel 257 Docetaxel 251 Sorafenib 236 S 1 (combination) 232 Folfox protocol 219 Albumin-Bound Paclitaxel 204 Surgical Procedures, Operative 178 durvalumab 177 apatinib 174 lenvatinib 167 tislelizumab 165 Radiosurgery 165 sintilimab 163 Carboplatin 152 Radiation 151 regorafenib 144

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡